我国药价虚高的法律规制
发布时间:2018-01-20 12:03
本文关键词: 药价虚高 宏观调控法 市场规制法 出处:《山西财经大学》2014年硕士论文 论文类型:学位论文
【摘要】:药品,严格区别于其他物品,但不可否认的是药品依然还是商品,是商品就需要经历研发、生产、流通并按照市场规律进行销售。因此,它具备商品的一切属性,也受价值规律的影响、市场的调节、法律的监管。 药品价格虚高的现状,已经严重损害了市场的竞争机制、侵害了消费者的合法权益,同时对构建社会主义和谐社会产生了更多不利的影响。我国人口众多,还未实现全民医保,还有许多民众的温饱问题没有解决,“因病致贫,因病返贫”的例子依然很多。 药品价格体系庞大且繁杂,涉及的环节颇为广泛,其中涉及药品的定价机制,政府监管,市场调解,生产流通,医院临床,药店零售等诸多领域。因此相关法律法规的缺失,政府监管、市场调节的双失灵,行业机制的不完善等诸多因素,导致药价虚高的问题愈演愈烈。 分析虚高的原因,在宏观角度看,是我国的药品制度不够完善:药品的定价机制和集中采购制度存在缺陷,医疗卫生体制不健全以及医疗保障制度存在缺陷。在微观角度看,是我国的市场规制不完善:药品市场结构不合理及市场行为不规范。因此,,分别从宏观调控法和市场规制法给出了对策:改革我国药品管理体制,调整和规范我国药品市场的结构及行为。
[Abstract]:Drugs are strictly different from other goods, but there is no denying that drugs are still or commodities. It is a commodity that needs to go through research and development, production, circulation and marketing in accordance with the market law. It has all the attributes of commodities, also affected by the law of value, the regulation of the market, the regulation of the law. The current situation of false high drug prices has seriously damaged the market competition mechanism, infringed on the legitimate rights and interests of consumers, at the same time, it has produced more adverse effects on the construction of a harmonious socialist society. China has a large population. Without universal health care, there are still many unsolved problems of people's food and clothing, and there are still many examples of "poverty caused by illness, return to poverty because of illness." Drug price system is huge and complicated, involving a wide range of links, including drug pricing mechanism, government regulation, market mediation, production and circulation, hospital clinical. Therefore, the lack of relevant laws and regulations, the double failure of government supervision, market regulation, and the imperfection of trade mechanism lead to the problem of false high drug price. From the macro point of view, the reason for the analysis of the false high is that the drug system in China is not perfect: the pricing mechanism of drugs and the centralized purchasing system are defective. The imperfect medical and health system and the defects of the medical security system. From the microscopic point of view, the market regulation of our country is not perfect: the structure of the medicine market is unreasonable and the market behavior is not standardized. The countermeasures are as follows: reforming the drug management system, adjusting and standardizing the structure and behavior of Chinese drug market.
【学位授予单位】:山西财经大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:D922.16;D922.294
【参考文献】
相关期刊论文 前10条
1 田坤;;我国药品价格管理中的“政府—医院—消费者”三方博弈分析[J];当代经济;2010年07期
2 徐金发,刘国辉;药价虚高的原因及对策研究[J];价格月刊;2003年07期
3 陈园;曹易;;我国药品价格虚高的原因及应对之策[J];科技创业月刊;2010年08期
4 李银才;;价值链与药品价格形成机制改革[J];现代经济探讨;2013年02期
5 常以;黄泰康;;英、德、日药品价格管制经验及其对我国的启示[J];价格月刊;2013年08期
6 刘振秋;李瑶光;王谈凌;;药品价格管理的国际经验借鉴及其启示——兼析德、法等国药品流通特点问题[J];价格理论与实践;2013年01期
7 廖浪霞;程鹏;刘利明;肖美华;;医疗改革中信息不对称与药品价格问题探讨[J];实用医技杂志;2013年02期
8 袁杰,刘红宁,肖宏浩,陈和利;“双失灵”与药价虚高[J];卫生经济研究;2005年11期
9 顾海;唐艳;邓晨珂;;我国药品集中招标采购制度的缺陷和对策[J];卫生经济研究;2006年07期
10 李先国;蒋阳阳;;药品价格虚高的成因及治理对策[J];现代营销(营销学苑);2008年07期
本文编号:1448123
本文链接:https://www.wllwen.com/falvlunwen/xingzhengfalunwen/1448123.html